MedTrace Logo

The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient

NCT00497978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 236

Last updated 2011-12-30

No results posted yet for this study

Summary

The purpose of this study is to reduce the postoperative morbidity and mortality in the elderly hip fracture patient, by giving them taurine peri-operatively.

Conditions

Interventions

DIETARY_SUPPLEMENT

taurine

6 grams of taurine will be given each day in capsules, starting the day of admission till the sixth postoperative day

DIETARY_SUPPLEMENT

placebo

a similar amount of placebo will be given each day in capsules, starting the day of admission till the sixth postoperative day

Sponsors & Collaborators

  • Medical Center Alkmaar

    lead OTHER

Principal Investigators

  • Alexander PJ Houdijk, MD, PhD · Medical Center Alkmaar

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00497978 on ClinicalTrials.gov